SIAG
BMY icon

Signet Investment Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History

Signet Investment Advisory Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$373K Hold
6,148
– – 0.17% 59
2025
Q4 		$332K Hold
6,148
– – 0.15% 62
2025
Q3 		$277K Hold
6,148
– – 0.13% 65
2025
Q2 		$285K Sell
6,148
-76
-1% -$3.73K 0.15% 62
2025
Q1 		$380K Sell
6,224
-2,037
-25% -$119K 0.19% 59
2024
Q4 		$467K Buy
8,261
+189
+2% +$10.6K 0.24% 60
2024
Q3 		$418K Sell
8,072
-45
-0.6% -$2.11K 0.21% 61
2024
Q2 		$337K Sell
8,117
-50
-0.6% -$2.24K 0.18% 61
2024
Q1 		$443K Sell
8,167
-5
-0.1% -$255 0.24% 59
2023
Q4 		$419K Buy
8,172
+200
+3% +$10.5K 0.25% 60
2023
Q3 		$463K Buy
7,972
+175
+2% +$10.7K 0.31% 58
2023
Q2 		$499K Hold
7,797
– – 0.33% 56
2023
Q1 		$540K Sell
7,797
-5
-0.1% -$353 0.37% 56
2022
Q4 		$561K Sell
7,802
-1,795
-19% -$135K 0.4% 57
2022
Q3 		$682K Sell
9,597
-325
-3% -$23.6K 0.53% 53
2022
Q2 		$764K Sell
9,922
-1,608
-14% -$122K 0.53% 55
2022
Q1 		$842K Sell
11,530
-35
-0.3% -$2.35K 0.51% 56
2021
Q4 		$721K Buy
11,565
+435
+4% +$25.5K 0.41% 59
2021
Q3 		$659K Buy
11,130
+1,995
+22% +$131K 0.42% 59
2021
Q2 		$610K Sell
9,135
-290
-3% -$18.9K 0.39% 64
2021
Q1 		$595K Buy
9,425
+485
+5% +$30.2K 0.46% 57
2020
Q4 		$555K Buy
+8,940
New +$550K 0.44% 52
2019
Q4 		$555K Buy
8,655
+2,060
+31% +$118K 0.52% 54
2019
Q3 		$334K Buy
6,595
+1,095
+20% +$51.5K 0.34% 59
2019
Q2 		$249K Buy
5,500
+950
+21% +$44.3K 0.26% 63
2019
Q1 		$217K Buy
4,550
+1,450
+47% +$72.2K 0.23% 66
2018
Q4 		$161K Buy
+3,100
New +$167K 0.18% 71

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Signet Investment Advisory Group's BMY Position: Q1 2026 in Review

Signet Investment Advisory Group held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 6,148 shares worth $373K. The position accounts for 0.17% of the portfolio, ranked #59.

Signet Investment Advisory Group first reported a position in BMY in Q4 2018 and has held it in 27 quarters since. The position peaked at $842K in Q1 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Signet Investment Advisory Group held 6,148 shares of Bristol-Myers Squibb worth $373K as of Q1 2026.
  • Signet Investment Advisory Group left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.17% of Signet Investment Advisory Group's portfolio in Q1 2026, its #59 holding.
  • Signet Investment Advisory Group first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 27 quarters since.
  • Signet Investment Advisory Group's Bristol-Myers Squibb position peaked at $842K in Q1 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Signet Investment Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.